1. What Is the Focused Ultrasound Brain Market?
The Focused Ultrasound Brain Market covers MRI-guided high-intensity focused ultrasound systems, transcranial low-intensity focused ultrasound neuromodulation devices, and pulsed HIFU tumor ablation platforms. These systems focus ultrasound energy through the skull to treat or modulate specific brain targets. Core applications include essential tremor and Parkinson's tremor thalamotomy, blood-brain barrier opening for drug delivery, glioblastoma tumor sonication, and non-invasive neuromodulation for depression and OCD. Market dynamics reflect FDA-cleared tremor HIFU market expansion, BBB opening drug delivery clinical trial advancement, and psychiatric indication development. Transcranial focused ultrasound neuromodulation without MRI guidance is an emerging market segment.
2. Focused Ultrasound Brain Market Size & Forecast
3. Emerging Technologies
- FUS-mediated sonodynamic therapy activating sonosensitizers within tumors for cancer treatment are advancing. Growing oncology investment is driven by sonodynamic therapy selectivity for brain tumor cell killing.
- Portable transcranial FUS neuromodulation systems enabling outpatient non-MRI guided treatment are advancing. Growing research and clinical adoption is driven by MRI independence enabling broader deployment.
- FUS thalamotomy bilateral tremor ablation expansion beyond approved unilateral ablation are advancing. Growing clinical program development is driven by bilateral tremor patient population needs.
- FUS BBB opening combined with CAR-T cell therapy CNS delivery for glioblastoma are advancing. Growing oncology adoption is driven by immunotherapy CNS delivery barrier elimination rationale.
Comparable technologies are influencing adjacent market segments in similar ways. Read more in our Neural Implant Market.
4. Key Market Opportunity
The primary opportunity in the Focused Ultrasound Brain Market is tremor HIFU center deployment. BBB opening drug delivery creates a clinical program partnership market for pharmaceutical companies. Transcranial FUS neuromodulation creates a non-invasive psychiatric brain stimulation opportunity. Asia Pacific focused ultrasound brain market expansion in Japan and China creates geographic opportunity.
5. Top Companies in the Focused Ultrasound Brain Market
The following organisations hold leading positions in the Focused Ultrasound Brain Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Insightec (Exablate Neuro)
- CarThera (SonoCloud BBB opening)
- FUS Foundation (research consortium)
- Brainsonix
- NeuroFocus (TUS neuromodulation)
- Sonic Concepts
- Profound Medical (TULSA prostate, brain pipeline)
- EpiguardHF (FUS)
- Alpinion (HIFU)
- Theraclion
6. Market Segmentation
The Focused Ultrasound Brain Market is analysed across 4 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Type | MRI-Guided HIFU Ablation Transcranial FUS Neuromodulation BBB-Opening Systems Pulsed FUS |
| By Application | Tremor Ablation BBB Drug Delivery Glioblastoma Psychiatric Neuromodulation Pain |
| By End User | Neurology Centers Neurosurgery Neuro-Oncology Research Institutions |
| By Geography | North America Europe Asia Pacific Latin America Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Focused Ultrasound Brain Market trajectory over the forecast period:
FDA-Cleared Essential Tremor HIFU Is Advancing Incisionless Thalamotomy Adoption.Insightec Exablate Neuro provides incisionless MRI-guided focused ultrasound thalamotomy. FDA clearance covers essential tremor and Parkinson's tremor unilateral thalamic ablation. HIFU thalamotomy avoids the craniotomy required for DBS electrode implantation. Growing tremor patient preference for non-surgical treatment is driving HIFU thalamotomy adoption.
Blood-Brain Barrier Opening Using Pulsed FUS Is Advancing Drug Delivery to Brain Tumors.Low-intensity pulsed FUS combined with microbubbles transiently opens the blood-brain barrier locally. BBB opening enables systemic chemotherapy and antibody drug access to otherwise impenetrable brain regions. CarThera SonoCloud and Insightec BBB opening programs are advancing glioblastoma drug delivery clinical trials. FUS BBB opening may transform brain drug delivery for glioblastoma, Alzheimer's, and Parkinson's treatment.
Non-Invasive Transcranial FUS Neuromodulation Is Advancing Psychiatric Treatment Without Electrodes.Transcranial focused ultrasound delivers neuromodulation to deep brain targets without scalp electrodes or implants. TUS demonstrates modulation of amygdala, anterior cingulate, and prefrontal cortex neural activity. Psychiatric TUS programs for depression, OCD, and PTSD are advancing in clinical pilot studies. Non-invasive TUS neuromodulation may provide brain stimulation without DBS implant surgery requirements.
For related market intelligence, see the Brain Computer Interface Market.
8. Segmental Analysis
By type, the MRI-Guided HIFU Ablation segment dominated the Focused Ultrasound Brain Market in 2025. FDA-cleared tremor thalamotomy with Insightec Exablate Neuro is the leading application. The BBB Opening Drug Delivery segment is fastest-growing, driven by glioblastoma combination therapy trials.
9. Regional Analysis
Regional demand patterns across the Focused Ultrasound Brain Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America dominated the Focused Ultrasound Brain Market in 2025 with a market share of 43.0%. The region hosts Insightec and the FDA-cleared essential tremor HIFU thalamotomy commercial market. NIH-funded FUS research programs and the Focused Ultrasound Foundation sustain academic platform development. Moreover, US neurology centers lead HIFU thalamotomy procedure adoption for tremor patients. FDA clearance and clinical leadership sustain North American market dominance.
Highest CAGR Region
Asia Pacific is projected to register the highest CAGR of 23.52% in the Focused Ultrasound Brain Market through 2034. Japan's PMDA clearance for HIFU tremor therapy is advancing neurology center deployment. China's growing neurology infrastructure and Parkinson's patient population create HIFU adoption opportunity. Moreover, South Korea's neurosurgical innovation programs are advancing transcranial FUS clinical development. Regulatory approval and neurology expansion position Asia Pacific for sustained Focused Ultrasound Brain Market outperformance.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology adoption trends and innovation tracking
- • Custom company profiling and benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country Trade Analysis
- • Country-level opportunity mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • List of Raw Material Suppliers
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Focused Ultrasound Brain Market was valued at USD 900.00 Mn in 2025 and is projected to reach USD 3,641.10 Mn by 2034, growing at a CAGR of 16.80% over the 2026–2034 forecast period.
The Focused Ultrasound Brain Market is projected to grow at a CAGR of 16.80% from 2026 to 2034.
North America dominated the Focused Ultrasound Brain Market in 2025 with a market share of 43.0%.
The leading companies in the Focused Ultrasound Brain Market include Insightec (Exablate Neuro), CarThera (SonoCloud BBB opening), FUS Foundation (research consortium), Brainsonix, NeuroFocus (TUS neuromodulation), Sonic Concepts, Profound Medical (TULSA prostate, brain pipeline), EpiguardHF (FUS), Alpinion (HIFU), Theraclion.
Fda-cleared essential tremor hifu is advancing incisionless thalamotomy adoption.
By type, the MRI-Guided HIFU Ablation segment dominated the Focused Ultrasound Brain Market in 2025.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.